Literature DB >> 16379007

Longitudinal analysis of human immunodeficiency virus type 1 nef/long terminal repeat sequences in a cohort of long-term survivors infected from a single source.

Melissa J Churchill1, David I Rhodes, Jennifer C Learmont, John S Sullivan, Steven L Wesselingh, Ian R C Cooke, Nicholas J Deacon, Paul R Gorry.   

Abstract

We studied the evolution of human immunodeficiency virus type 1 (HIV-1) in a cohort of long-term survivors infected with an attenuated strain of HIV-1 acquired from a single source. Although the cohort members experienced differing clinical courses, we demonstrate similar evolution of HIV-1 nef/long-terminal repeat (LTR) sequences, characterized by progressive sequence deletions tending toward a minimal nef/LTR structure that retains only sequence elements required for viral replication. The in vivo pathogenicity of attenuated HIV-1 is therefore dictated by viral and/or host factors other than those that impose a unidirectional selection pressure on the nef/LTR region of the HIV-1 genome.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16379007      PMCID: PMC1346882          DOI: 10.1128/JVI.80.2.1047-1052.2006

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

1.  An examination of signs of disease progression in survivors of the Sydney Blood Bank Cohort (SBBC).

Authors:  M R Birch; J C Learmont; W B Dyer; N J Deacon; J J Zaunders; N Saksena; A L Cunningham; J Mills; J S Sullivan
Journal:  J Clin Virol       Date:  2001-10       Impact factor: 3.168

2.  Disrupting surfaces of nef required for downregulation of CD4 and for enhancement of virion infectivity attenuates simian immunodeficiency virus replication in vivo.

Authors:  A J Iafrate; S Carl; S Bronson; C Stahl-Hennig; T Swigut; J Skowronski; F Kirchhoff
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Importance of the nef gene for maintenance of high virus loads and for development of AIDS.

Authors:  H W Kestler; D J Ringler; K Mori; D L Panicali; P K Sehgal; M D Daniel; R C Desrosiers
Journal:  Cell       Date:  1991-05-17       Impact factor: 41.582

4.  Pathogenic conversion of live attenuated simian immunodeficiency virus vaccines is associated with expression of truncated Nef.

Authors:  E T Sawai; M S Hamza; M Ye; K E Shaw; P A Luciw
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

5.  Characterization of three nef-defective human immunodeficiency virus type 1 strains associated with long-term nonprogression. Australian Long-Term Nonprogressor Study Group.

Authors:  D I Rhodes; L Ashton; A Solomon; A Carr; D Cooper; J Kaldor; N Deacon
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

6.  Identification of attenuated variants of HIV-1 circulating recombinant form 01_AE that are associated with slow disease progression due to gross genetic alterations in the nef/long terminal repeat sequences.

Authors:  Makiko Kondo; Takako Shima; Masako Nishizawa; Koji Sudo; Shinya Iwamuro; Takeshi Okabe; Yutaka Takebe; Mitsunobu Imai
Journal:  J Infect Dis       Date:  2005-05-25       Impact factor: 5.226

7.  Long-term symptomless HIV-1 infection in recipients of blood products from a single donor.

Authors:  J Learmont; B Tindall; L Evans; A Cunningham; P Cunningham; J Wells; R Penny; J Kaldor; D A Cooper
Journal:  Lancet       Date:  1992-10-10       Impact factor: 79.321

8.  Coreceptor phenotype of natural human immunodeficiency virus with nef deleted evolves in vivo, leading to increased virulence.

Authors:  Andreas Jekle; Birgit Schramm; Prerana Jayakumar; Verena Trautner; Dominique Schols; Erik De Clercq; John Mills; Suzanne M Crowe; Mark A Goldsmith
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

9.  Determinants of increased replicative capacity of serially passaged simian immunodeficiency virus with nef deleted in rhesus monkeys.

Authors:  Louis Alexander; Petr O Illyinskii; Sabine M Lang; Robert E Means; Jeffrey Lifson; Keith Mansfield; Ronald C Desrosiers
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

10.  Live attenuated, nef-deleted SIV is pathogenic in most adult macaques after prolonged observation.

Authors:  Regina Hofmann-Lehmann; Josef Vlasak; Alison L Williams; Agnès-Laurence Chenine; Harold M McClure; Daniel C Anderson; Shawn O'Neil; Ruth M Ruprecht
Journal:  AIDS       Date:  2003-01-24       Impact factor: 4.177

View more
  36 in total

1.  Neutron reflectometry study of the conformation of HIV Nef bound to lipid membranes.

Authors:  Michael S Kent; Jaclyn K Murton; Darryl Y Sasaki; Sushil Satija; Bulent Akgun; Hirsh Nanda; Joseph E Curtis; Jaroslaw Majewski; Christopher R Morgan; John R Engen
Journal:  Biophys J       Date:  2010-09-22       Impact factor: 4.033

2.  Combinatorial latency reactivation for HIV-1 subtypes and variants.

Authors:  John C Burnett; Kwang-Il Lim; Arash Calafi; John J Rossi; David V Schaffer; Adam P Arkin
Journal:  J Virol       Date:  2010-03-31       Impact factor: 5.103

3.  Construction of a doxycycline-dependent simian immunodeficiency virus reveals a nontranscriptional function of tat in viral replication.

Authors:  Atze T Das; Bep Klaver; Alex Harwig; Monique Vink; Marcel Ooms; Mireille Centlivre; Ben Berkhout
Journal:  J Virol       Date:  2007-08-01       Impact factor: 5.103

4.  Transcriptional activity of blood-and cerebrospinal fluid-derived nef/long-terminal repeat sequences isolated from a slow progressor infected with nef-deleted human immunodeficiency virus type 1 (HIV-1) who developed HIV-associated dementia.

Authors:  Melissa J Churchill; Anna Figueiredo; Daniel Cowley; Lachlan Gray; Damian Fj Purcell; John S Sullivan; Dale A McPhee; Steven L Wesselingh; Bruce J Brew; Paul R Gorry
Journal:  J Neurovirol       Date:  2006-06       Impact factor: 2.643

5.  Changes in the V3 region of gp120 contribute to unusually broad coreceptor usage of an HIV-1 isolate from a CCR5 Delta32 heterozygote.

Authors:  Paul R Gorry; Rebecca L Dunfee; Megan E Mefford; Kevin Kunstman; Tom Morgan; John P Moore; John R Mascola; Kristin Agopian; Geoffrey H Holm; Andrew Mehle; Joann Taylor; Michael Farzan; Hui Wang; Philip Ellery; Samantha J Willey; Paul R Clapham; Steven M Wolinsky; Suzanne M Crowe; Dana Gabuzda
Journal:  Virology       Date:  2007-01-18       Impact factor: 3.616

Review 6.  Animal models for depression associated with HIV-1 infection.

Authors:  Isabella Cristina Gomes Barreto; Patricia Viegas; Edward B Ziff; Elisabete Castelon Konkiewitz
Journal:  J Neuroimmune Pharmacol       Date:  2013-12-12       Impact factor: 4.147

7.  Modulation of HIV pathogenesis and T-cell signaling by HIV-1 Nef.

Authors:  Shailendra K Saxena; Gaurav Shrivastava; Sneham Tiwari; Ml Arvinda Swamy; Madhavan Pn Nair
Journal:  Future Virol       Date:  2012-06-01       Impact factor: 1.831

8.  Function of ubiquitin (Ub) specific protease 15 (USP15) in HIV-1 replication and viral protein degradation.

Authors:  Dohun Pyeon; Khalid Amine Timani; Fahad Gulraiz; Johnny J He; In-Woo Park
Journal:  Virus Res       Date:  2016-07-25       Impact factor: 3.303

9.  Meta-analysis to test the association of HIV-1 nef amino acid differences and deletions with disease progression.

Authors:  Ravindra Pushker; Jean-Marc Jacqué; Denis C Shields
Journal:  J Virol       Date:  2010-01-13       Impact factor: 5.103

10.  Elite suppressor-derived HIV-1 envelope glycoproteins exhibit reduced entry efficiency and kinetics.

Authors:  Kara G Lassen; Michael A Lobritz; Justin R Bailey; Samantha Johnston; Sandra Nguyen; Benhur Lee; Tom Chou; Robert F Siliciano; Martin Markowitz; Eric J Arts
Journal:  PLoS Pathog       Date:  2009-04-10       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.